We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Monthly Production Capacity: 20kgs
Delivery Lead Time: 2 weeks
Sample Provided: yes
Payment Terms: T/T
General description
Recombinant human serum albumin (rHSA) is genetically engineered and derived from CHO expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
CAS NO.: 70024-90-7
Source:Recombinant (No animal components are used in the manufacturing process of this product, animal-free material.)
Form: Lyophilized
Mol. Weight: 66.5 kDa
Appearance: White to light-yellow powder
Purity: ≥99% (SDS-PAGE)
Endotoxin: < 0.1EU/μg (kinetic LAL)
Package: 1g,10g,100g,500g
Storage&Shift life: -20ºC 2years
Application: Cell Culture
Advantages:
Plant based expression system
More homogeneous than HSA
Lack of toxicity and immunogenicity
Provides a well-defined and consistent medium
Animal- and virus-free and higher safety than HSA, no regulatory issues
High purity and better batch consistency compared to FBS, BSA and plasma-derived HSA Limitations: For LABORATORY RESEARCH USE ONLY and is not approved for use in humans or clinical.
Audited Supplier
Pharma Sources Insight JANUARY 2024
